Please join Washington Hospital Services Industry Partner SUNRx for a webinar panel on manufacturer mandates and 340B ESP from 11 a.m. to noon Thursday, Nov. 10. AuthorityRx President Aaron Lott and Managing Principal, Account Management of SUNRx Donna Petty will share insights on how your organization can plan for an efficient and compliant 340B claims capture program. Register here.
The current environment created by some drug companies has levied significant disruption on the administration of the 340B drug pricing program and in turn created financial shortfalls for entities across the country. Though the mission of 340B ESP is to bring pharmaceutical manufacturers and 340B covered entities together to improve 340B program transparency, several common stakeholder challenges have surfaced that are creating significant disruption.
When an entity can learn more about these challenges, the results can be beneficial in realizing more savings available from the 340B pricing program. Entities must stay vigilant and compliantly optimize their 340B claims capture programs.
This panel discussion will help provide valuable insights on how your entity can effectively manage their engagement with 340B ESP that includes:
- Historical review: How did our current state of regulatory affairs get here?
- Current regulatory environment: Provide a review of current regulatory activity.
- Implications moving forward: Things your entity should consider moving forward.
If you’d like to learn more about the WHS Industry Partner Program, or have questions about the SunRx 340B program management, contact Ed Phippen, edp@wsha.org, (206) 216-2556. (Cynthia Hay)
